DK1146897T3 - Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle - Google Patents

Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Info

Publication number
DK1146897T3
DK1146897T3 DK00906234T DK00906234T DK1146897T3 DK 1146897 T3 DK1146897 T3 DK 1146897T3 DK 00906234 T DK00906234 T DK 00906234T DK 00906234 T DK00906234 T DK 00906234T DK 1146897 T3 DK1146897 T3 DK 1146897T3
Authority
DK
Denmark
Prior art keywords
mia
cartilage
activity factor
inhibitory activity
bone repair
Prior art date
Application number
DK00906234T
Other languages
Danish (da)
English (en)
Inventor
Carola Dony
Gabriele Proetzel
Ulrike Leser-Reiff
Original Assignee
Carola Dony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carola Dony filed Critical Carola Dony
Application granted granted Critical
Publication of DK1146897T3 publication Critical patent/DK1146897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00906234T 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle DK1146897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101315A EP1025871A1 (fr) 1999-01-28 1999-01-28 Utilisation d'un facteur à activité inhibitrice du mélanome pour la réparation de cartilage et des os
PCT/EP2000/000623 WO2000044401A1 (fr) 1999-01-28 2000-01-27 Utilisation d'un facteur d'activite inhibitrice de melanome (mia) pour la reparation de cartilages et d'os

Publications (1)

Publication Number Publication Date
DK1146897T3 true DK1146897T3 (da) 2003-02-03

Family

ID=8237403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906234T DK1146897T3 (da) 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Country Status (11)

Country Link
US (1) US6890897B1 (fr)
EP (2) EP1025871A1 (fr)
JP (2) JP4800483B2 (fr)
AT (1) ATE224731T1 (fr)
AU (1) AU765929B2 (fr)
CA (1) CA2361238C (fr)
DE (1) DE60000501T2 (fr)
DK (1) DK1146897T3 (fr)
ES (1) ES2180514T3 (fr)
PT (1) PT1146897E (fr)
WO (1) WO2000044401A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467252C (fr) * 2001-10-25 2008-12-02 Japan Science And Technology Agency Substance biologique composite
AU2003244459A1 (en) * 2002-02-04 2003-09-02 Koken Co., Ltd. Preparations for treating bone fracture or bone loss or elevating bone density
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR20080084808A (ko) 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
ES2443581T3 (es) 2006-02-09 2014-02-19 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
AU2007269712B2 (en) 2006-06-30 2013-02-07 Biomimetic Therapeutics, Llc PDGF-biomatrix compositions and methods for treating rotator cuff injuries
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US7671014B2 (en) 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
JP5484059B2 (ja) * 2006-10-06 2014-05-07 エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 脊髄核インプラント
WO2008073628A2 (fr) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions et procédés pour procédures arthrodétiques
AU2009212151C1 (en) 2008-02-07 2015-09-17 Stryker Corporation Compositions and methods for distraction osteogenesis
US9616153B2 (en) 2008-04-17 2017-04-11 Warsaw Orthopedic, Inc. Rigid bone graft substitute
BR122020000059B8 (pt) 2008-09-09 2021-06-22 Biomimetic Therapeutics Inc composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit
BR112012020566B1 (pt) 2010-02-22 2021-09-21 Biomimetic Therapeutics, Llc Composição de fator de crescimento derivado de plaqueta
SG10201502398RA (en) 2010-04-27 2015-05-28 Scil Technology Gmbh Stable MIA/CD-RAP formulations
WO2018129470A1 (fr) * 2017-01-09 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Inversion de signalisation hedgehog déficiente restaurant la régénération squelettique déficiente

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
WO1992009697A1 (fr) * 1990-11-30 1992-06-11 Celtrix Laboratories, Inc. UTILISATION EN OSTEOPATHIE D'UNE PROTEINE MORPHOGENETIQUE D'ORIGINE OSSEUSE ASSOCIEE DE MANIERE SYNERGIQUE AVEC DU BETA DE FACTEUR DE CROISSANCE DE TRANSFORMATION (β-FCT).
JP3435163B2 (ja) * 1993-07-20 2003-08-11 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 黒色腫阻害蛋白質
TW369414B (en) * 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JPH10194987A (ja) * 1997-01-14 1998-07-28 Youtai Iwamoto 骨・軟骨形成用組成物
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
ATE224731T1 (de) 2002-10-15
ES2180514T3 (es) 2003-02-16
AU765929B2 (en) 2003-10-02
EP1025871A1 (fr) 2000-08-09
JP2011084574A (ja) 2011-04-28
EP1146897A1 (fr) 2001-10-24
AU2799000A (en) 2000-08-18
DE60000501D1 (de) 2002-10-31
CA2361238C (fr) 2010-08-10
EP1146897B1 (fr) 2002-09-25
DE60000501T2 (de) 2003-02-13
JP4800483B2 (ja) 2011-10-26
PT1146897E (pt) 2003-02-28
US6890897B1 (en) 2005-05-10
JP2002537229A (ja) 2002-11-05
WO2000044401A1 (fr) 2000-08-03
CA2361238A1 (fr) 2000-08-03

Similar Documents

Publication Publication Date Title
DK1146897T3 (da) Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle
NO962304D0 (no) BMP-12, BMP-13 og sene-induserende sammensetninger derav
ATE253385T1 (de) Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
DE69528058D1 (de) Bmp-9 zusammensetzungen
DE59706273D1 (de) Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
ES2113857T3 (es) Composiciones osteoinductoras.
DE59711081D1 (de) Marknagelsystem zur frakturheilung bzw. knochenverlängerung
DE69720177D1 (de) Markraumnagel für die Versorgung von Frakturen der Hüfte
DK1690874T3 (da) BMP-12, BMP-13 og sene-inducerende sammensætninger deraf
DE69926800D1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
NO973400D0 (no) Nye aminoderivater som inhibitorer av benresorpsjon og vitronektinreseptorantagonister
BR9704072A (pt) Derivados de cicloalquila como inibidores de ressorção de ossos e antagonistas de receptores vitronectina
NO20005928D0 (no) Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon
DE602004013281D1 (de) Artikulierbares implantatsystem
DE60041782D1 (de) Bioaktiver und osteoporotischer knochenzement
EE9900006A (et) Uued amidinoderivaadid ja nende kasutamine trombiini inhibiitoritena
EP1095159A4 (fr) Proteine morphogenetique osseuse
DE60221804D1 (de) Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
ATE277902T1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
EP1150684A4 (fr) Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes
ATE231883T1 (de) Neuartige aminosäurederivate und deren verwendung als thrombininhibitoren
ATE273031T1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
DK1027086T3 (da) Formede legemer til anvendelse som implantater i humanmedicin og metode til fremstilling af sådanne formede legemer
DE68913991D1 (de) Implantat zur verwendung in der knochenchirurgie.
DE60019389D1 (de) Chirurgischer Schwenkhaltering zur Verwendung in der Augenchirurgie